- Home
- DERM vs HCAT Comparison
DERM vs HCAT Comparison
Compare DERM & HCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- HCAT
- Stock Information
- Founded
- DERM 2014
- HCAT 2008
- Country
- DERM United States
- HCAT United States
- Employees
- DERM N/A
- HCAT N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- HCAT Computer Software: Programming Data Processing
- Sector
- DERM Health Care
- HCAT Technology
- Exchange
- DERM Nasdaq
- HCAT Nasdaq
- Market Cap
- DERM 190.7M
- HCAT 223.8M
- IPO Year
- DERM 2021
- HCAT 2019
- Fundamental
- Price
- DERM $7.94
- HCAT $3.34
- Analyst Decision
- DERM Strong Buy
- HCAT Hold
- Analyst Count
- DERM 3
- HCAT 11
- Target Price
- DERM $12.67
- HCAT $4.50
- AVG Volume (30 Days)
- DERM 153.4K
- HCAT 475.1K
- Earning Date
- DERM 11-07-2025
- HCAT 11-10-2025
- Dividend Yield
- DERM N/A
- HCAT N/A
- EPS Growth
- DERM N/A
- HCAT N/A
- EPS
- DERM N/A
- HCAT N/A
- Revenue
- DERM $56,397,000.00
- HCAT $316,093,000.00
- Revenue This Year
- DERM $26.16
- HCAT $3.85
- Revenue Next Year
- DERM $45.27
- HCAT N/A
- P/E Ratio
- DERM N/A
- HCAT N/A
- Revenue Growth
- DERM N/A
- HCAT 5.55
- 52 Week Low
- DERM $3.54
- HCAT $2.52
- 52 Week High
- DERM $8.90
- HCAT $9.24
- Technical
- Relative Strength Index (RSI)
- DERM 66.43
- HCAT 60.00
- Support Level
- DERM $7.38
- HCAT $3.05
- Resistance Level
- DERM $8.20
- HCAT $3.55
- Average True Range (ATR)
- DERM 0.36
- HCAT 0.16
- MACD
- DERM 0.09
- HCAT 0.06
- Stochastic Oscillator
- DERM 93.80
- HCAT 77.81
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About HCAT Health Catalyst Inc
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.